ARCT fell a whopping 66% the past 2 days. The catalyst was the inability of its COVID vaccine to produce levels of antibodies comparable to other vaccines in development or already developed. You can check more here: www.investors.com
It found support around $41.5 and moved about 12% to the upside to only fall again. It is currently hovering over the $44.3...
